{"id":532894,"date":"2026-07-04T15:53:08","date_gmt":"2026-07-04T15:53:08","guid":{"rendered":"https:\/\/www.newsbeep.com\/ie\/532894\/"},"modified":"2026-07-04T15:53:08","modified_gmt":"2026-07-04T15:53:08","slug":"glp-1-use-tied-to-smell-and-taste-disturbances-emj","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ie\/532894\/","title":{"rendered":"GLP-1 Use Tied to Smell and Taste Disturbances \u2013 EMJ"},"content":{"rendered":"<p><a href=\"https:\/\/www.emjreviews.com\/diabetes\/news\/uk-approves-first-glp-1-weight-loss-tablet-for-obesity-treatment\/\" rel=\"nofollow noopener\" target=\"_blank\">GLUCAGON-LIKE PEPTIDE-1<\/a>\u00a0(GLP-1) receptor agonist therapy is linked to a higher risk of\u00a0smell and taste disturbances\u00a0in patients with\u00a0<a href=\"https:\/\/www.emjreviews.com\/diabetes\/news\/anxiety-associated-with-grazing-in-type-2-diabetes\/\" rel=\"nofollow noopener\" target=\"_blank\">Type 2 diabetes<\/a>, a new multicentre\u00a0retrospective cohort study has found.\u00a0\u00a0<\/p>\n<p>GLP-1 Receptor Agonists\u00a0<\/p>\n<p>GLP-1 receptor agonists have gained traction in recent years as a popular\u00a0option\u00a0for glycaemic control and weight loss.\u00a0<\/p>\n<p>Various adverse events have been reported by users, however the potential impact of GLP-1s on smell and taste has previously been unknown.\u00a0<\/p>\n<p>The Study\u00a0<\/p>\n<p>Researchers analysed electronic health records from 5th\u00a0December 2017 to 20th\u00a0April 2026, with a follow-up of up to two years after beginning treatment with GLP-1s.\u00a0<\/p>\n<p>Patients above age 18 years,\u00a0who were diagnosed with Type 2 diabetes with no record of smell or taste disturbances,\u00a0were split into two groups:\u00a0patients prescribed Type 2 diabetes medications that were not GLP-1s (control) and patients\u00a0who received GLP-1 prescriptions after their first recorded diagnosis of Type 2 diabetes.\u00a0\u00a0<\/p>\n<p>Each cohort included 438,474 patients.\u00a0<\/p>\n<p>In the control\u00a0group, patients had a mean age of\u00a057.6 years and 56% were female.\u00a0<\/p>\n<p>In the GLP-1 cohort, there was a mean age of 57.7 years and\u00a054.9% were female.\u00a0\u00a0<\/p>\n<p>48% Higher Rate of Smell and Taste Disturbances\u00a0<\/p>\n<p>Patients who used GLP-1s had a\u00a048% higher rate\u00a0of developing smell and taste disturbances, compared with the control group.\u00a0<\/p>\n<p>The GLP-1 group had an 81% higher rate of developing smell disturbances, and 52% higher rate of developing taste disturbances, than those taking\u00a0other antidiabetic medications.\u00a0\u00a0<\/p>\n<p>Findings were consistent throughout the follow-up period.\u00a0<\/p>\n<p>Clinical Implications\u00a0<\/p>\n<p>Researchers\u00a0called for\u00a0the\u00a0closer monitoring of patients taking GLP-1s ,\u00a0alongside greater public health awareness of the\u00a0medication\u2019s\u00a0side effects.\u00a0<\/p>\n<p>Future research, they reported, is necessary to\u00a0validate\u00a0the findings and analyse the underlying pathways and mechanisms that\u00a0may\u00a0cause the disturbances.\u00a0<\/p>\n<p>Reference\u00a0<\/p>\n<p>Zontag\u00a0J,\u00a0Zontag\u00a0N.\u00a0Smell\u00a0and taste disturbances among glucagon-like peptide-1 receptor agonist users. JAMA\u00a0Otolaryngol\u00a0Head Neck Surg.\u00a02026;DOI:10.1001\/jamaoto.2026.1498.\u00a0<\/p>\n<p>Featured image:\u00a0DimaBerlin\u00a0on Adobe Stock\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"GLUCAGON-LIKE PEPTIDE-1\u00a0(GLP-1) receptor agonist therapy is linked to a higher risk of\u00a0smell and taste disturbances\u00a0in patients with\u00a0Type 2&hellip;\n","protected":false},"author":2,"featured_media":532895,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[103,61,60],"class_list":["post-532894","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-health","tag-ie","tag-ireland"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/532894","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/comments?post=532894"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/532894\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media\/532895"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media?parent=532894"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/categories?post=532894"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/tags?post=532894"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}